Vectivbio AG

ACTIVE

Unknown Belgian address 0, Unknown, Switzerlandwww.vectivbio.comPublic51–100 employeesEstablished: 2019-01-01

Part of Ironwood医药

Clinical Trials

28 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2019

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

75.0%

Phase 3

10.0%

Phase 2

5.0%

Trial Status Distribution

Active, not recruiting

70.0%

Completed

20.0%

Recruiting

7.5%

Terminated

2.5%

Clinical Trials

Trials sponsored by this organization (40)

A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)

Phase 3

Recruiting

interventional

Aug 2026124 participants

ong-term safety of apraglutide in short bowel syndrome

Phase 1

Active, not recruiting

interventional

May 2024154 participants

Efficacy and Safety of apraglutide in steroid refractory gastrointestinal acute graft versus host disease.

Phase 1

Active, not recruiting

interventional

Apr 202429 participants

Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation

Phase 1

Completed

interventional

May 202334 participants

A Randomized, Open-label, Single Dose, 3-Period, 6-Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Apraglutide Versus the Reference Formulation Following Subcutaneous Administrations.

Phase 1

Active, not recruiting

Apr 202333 participants

Evaluation of Apraglutide on Gastric Emptying

Phase 1

Completed

interventional

Mar 202342 participants

ong-term safety of apraglutide in short bowel syndrome

Phase 1

Active, not recruiting

interventional

Feb 2023154 participants

A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function

Phase 1

Completed

interventional

Jan 202316 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

Back to Organizations